Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.2M
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
11.7M
-
Shares change
-
-284K
-
Total reported value, excl. options
-
$763M
-
Value change
-
-$25.1M
-
Put/Call ratio
-
1.53
-
Number of buys
-
67
-
Number of sells
-
-46
-
Price
-
$64.99
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q3 2022
169 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock as of Q3 2022.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.7M shares
of 22.2M outstanding shares and own 52.89% of the company stock.
Largest 10 shareholders include Avoro Capital Advisors LLC (1.54M shares), BAKER BROS. ADVISORS LP (1.5M shares), VANGUARD GROUP INC (1.25M shares), ARMISTICE CAPITAL, LLC (1.24M shares), BlackRock Inc. (1M shares), STATE STREET CORP (967K shares), PERCEPTIVE ADVISORS LLC (331K shares), Rock Springs Capital Management LP (317K shares), FEDERATED HERMES, INC. (240K shares), and GEODE CAPITAL MANAGEMENT, LLC (230K shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.